James L. Murray

Statistics

Publications

Citations

220

H-Index

Active since

1991

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Breast Cancer Care

James L. Murray is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, pharmacology, and administration of monoclonal antibodies.

Publications per year

1991–1999

Publications

Increased glutathione peroxidase activity in a human sarcoma cell line with inherent doxorubicin resistance.

Brian L. Samuels, James L. Murray, M. Cohen et al. · PubMed · 1991 · 71 citations

Medicine, Oncology, Pharmacology +13

Phase Ia/Ib Trial of Anti-GD2 Chimeric Monoclonal Antibody 14.18 (ch l4.18) and Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (rhGM-CSF) in Metastatic Melanoma

James L. Murray, Eugenie Kleinerman, Shu-Fang Jia et al. · Journal of Immunotherapy · 1996 · 39 citations

Life Sciences, Immunology, Oncology +17

Effect of recombinant alpha-interferon on pharmacokinetics, biodistribution, toxicity, and efficacy of 131I-labeled monoclonal antibody CC49 in breast cancer: a phase II trial.

Daniel J. Macey, Edward Grant, Leela P. Kasi et al. · PubMed · 1997 · 36 citations

Medicine, Oncology, Pharmacology +17

Phase II study of vinorelbine administered by 96-hour infusion in patients with advanced breast carcinoma

Nuhad K. Ibrahim, Zia Ur Rahman, Vicente Valero et al. · Cancer · 1999 · 23 citations

Medicine, Oncology, Pharmacology +17

Phase I clinical and pharmacological study of suppression of human antimouse antibody response to monoclonal antibody L6 by deoxyspergualin.

Kapil Dhingra, Herbert A. Fritsche, James L. Murray et al. · PubMed · 1995 · 23 citations

Pharmacy, Immunology, Pharmacology +16

1–5 of 7